National and Kapodistrian University of Athens
Analysis of the role of intracellular peptide catabolism in the immunopeptidome, proteome and metabolism of cancer cells
Abstract
dc:descriptionEndoplasmic reticulum aminopeptidase 1 (ERAP1) is an enzyme located in the endoplasmic reticulum (ER), that trims antigenic peptide precursors for Major Histocompatibility Complex class I presentation. As a result, ERAP1 has been proposed to constitute a key regulator of the cellular immunopeptidome, and modulating its activity is a promising strategy for cancer immunotherapy and the treatment of HLA-associated autoimmunity. However, before clinical application, a deeper understanding of ERAP1’s biological role and mechanism of function in both cells and intact organisms is necessary. Moreover, ERAP1 is hypothesised to have additional, yet poorly characterised roles. Furthermore, ERAP1 is polymorphic, with ten main allotypes in the human population. These allotypes differ in enzymatic activities and substrate specificities and have been associated with disease predisposition. However, their exact role in shaping the immunopeptidome and disease mechanisms is not clear. To address these gaps, I employed immunopeptidomics, label-free quantitative proteomics, and other biochemical techniques to investigate the role of ERAP1 modulation and allotypic variation on antigen presentation and cellular functions. My results show how ERAP1 activity can shape the immunopeptidome in multiple cancer cell lines and tumours. Moreover, ERAP1 functional disruption alters the cellular proteome and affects ER homeostasis and cellular metabolism. ERAP1 allotypic variation can induce qualitative and quantitative changes on the immunopeptidome of cancer cells in patterns that may contribute to the development of autoimmunity. Overall, this study further establishes the important role and mechanism of ERAP1 and its allotypes in shaping antigen presentation, highlights previously unknown secondary biological functions and further validates it as a target for cancer immunotherapy and the treatment of certain forms of autoimmunity.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikopaschou, Martha-Spyridoula
- Νικοπάσχου, Μάρθα-Σπυριδούλα
Subjects
dc:subject × 16Rights
- Language dc:language
- eng
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59187